300 related articles for article (PubMed ID: 22178066)
1. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB
Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factor.
Sovershaev MA; Egorina EM; Bogdanov VY; Seredkina N; Fallon JT; Valkov AY; Østerud B; Hansen JB
Thromb Res; 2010 Oct; 126(4):306-10. PubMed ID: 20656331
[TBL] [Abstract][Full Text] [Related]
3. Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression.
Egorina EM; Sovershaev MA; Bogdanov VY; Sovershaev TA; Fallon JT; Seredkina N; Østerud B; Hansen JB
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):642-50. PubMed ID: 21897206
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
Migdalski A; Kotschy M; Jawien A
Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
[TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
Zawadzki C; Susen S; Richard F; Haulon S; Corseaux D; Jeanpierre E; Vincentelli A; Lucas C; Torpier G; Martin A; Van Belle E; Staels B; Jude B
Atherosclerosis; 2007 Dec; 195(2):e117-25. PubMed ID: 17196206
[TBL] [Abstract][Full Text] [Related]
6. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
[TBL] [Abstract][Full Text] [Related]
7. Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: results from a 1-year follow-up study.
Krupinski J; Turu MM; Font MA; Catena E; Slevin M; Morchon S; Rubio F; Badimon L; Martínez-González J
Cerebrovasc Dis; 2008; 25(1-2):32-9. PubMed ID: 18033956
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor expression in atherosclerosis.
Drew AF; Davenport P; Apostolopoulos J; Tipping PG
Lab Invest; 1997 Oct; 77(4):291-8. PubMed ID: 9354763
[TBL] [Abstract][Full Text] [Related]
9. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis.
Hutter R; Valdiviezo C; Sauter BV; Savontaus M; Chereshnev I; Carrick FE; Bauriedel G; Lüderitz B; Fallon JT; Fuster V; Badimon JJ
Circulation; 2004 Apr; 109(16):2001-8. PubMed ID: 15078795
[TBL] [Abstract][Full Text] [Related]
10. Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology.
Wahlgren CM; Zheng W; Shaalan W; Tang J; Bassiouny HS
Cerebrovasc Dis; 2009; 27(2):193-200. PubMed ID: 19136823
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients.
Sardo MA; Campo S; Castaldo M; Bonaiuto A; Bitto A; Saitta C; Cristadoro S; Trimarchi G; Saitta A
J Hypertens; 2006 Apr; 24(4):731-6. PubMed ID: 16531802
[TBL] [Abstract][Full Text] [Related]
12. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
13. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
14. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
Basavaraj MG; Gruber FX; Sovershaev M; Appelbom HI; Osterud B; Petersen LC; Hansen JB
Thromb Res; 2010 Nov; 126(5):418-25. PubMed ID: 20723970
[TBL] [Abstract][Full Text] [Related]
15. LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression.
Øvstebø R; Aass HC; Haug KB; Trøseid AM; Gopinathan U; Kierulf P; Berg JP; Brandtzaeg P; Henriksson CE
Innate Immun; 2012 Aug; 18(4):580-91. PubMed ID: 22180561
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor/TFPI and blood cells.
Osterud B
Thromb Res; 2012 Mar; 129(3):274-8. PubMed ID: 22197177
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
18. Relevance of tissue factor in cardiovascular disease.
Jude B; Zawadzki C; Susen S; Corseaux D
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):667-71. PubMed ID: 16007822
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor in acute coronary syndromes.
Ott I
Semin Vasc Med; 2003 May; 3(2):185-92. PubMed ID: 15199481
[TBL] [Abstract][Full Text] [Related]
20. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
Caplice NM; Mueske CS; Kleppe LS; Simari RD
Circulation; 1998 Sep; 98(11):1051-7. PubMed ID: 9736590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
